This site is intended for health professionals only
Saturday 25 May 2019
Share |

Roche cancer drugs push sales to record highs

Swiss-based drug major Roche posted record figures for 2007 showing that revenues rose 10% to 46.13bn Swiss francs, while net income soared 25% to 11.44 bn francs ($10.5bn).

Drug sales, excluding contributions from subsidiaries Genentech and Chugai, were up 11% to 22.97bn francs, driven by sales of the division's oncology products.

Globally, MabThera®/Rituxan® (rituximab) for non-Hodgkin's lymphoma grew 15% to 5.52bn francs, and sales of Herceptin® (trastuzumab) grew 23% to 4.85n francs.

Avastin® (bevacizumab) increased 41% to 4.11bn francs and Tarceva® (erlotinib) 31% to 1.06 bn francs.

Transplantation products CellCept® (mycophenolate mofetil) and Valcyte®/Cymevene® (valganciclovir/ganciclovir) rose 10% and 12% respectively to $2.01bn and $542m.

Roche's hepatitis C treatment Pegasys® (peginterferon alfa) increased 11% to 1.64bn francs, while osteoporosis drug Boniva/Bonviva® (ibandronic acid) climbed 85% to 887m francs.

However there was disappointment with sales of the influenza vaccine Tamiflu® (oseltamivir), which fell back 19% globally to 2.09bn francs. This was expected, as most existing pandemic stockpiling orders have been fulfilled and sales for next year are expected to fall even further.

The results beat analysts' expectations and Roche is predicting more of the same in the next few years.

Despite anticipated lower Tamiflu sales and "significantly higher R&D spending", Roche expects earnings to "remain at least in line" with 2007.

The Basle-based group anticipates continued strong growth in 2009-10, aided by the launch of the rheumatoid arthritis drug Actemra® (tocilizumab) and the anaemia treatment Mircera® (methoxy polyethylene glycol-epoetin beta).

Roche

Ads by Google

You are leaving www.nursinginpractice.com

You are currently leaving the Nursing in Practice site. Are you sure you want to proceed?

Close

Respect for nurses: Sign up to our e-petition TODAY

The Nursing in Practice Respect campaign is now live! Over the coming months, we're set to highlight the vital contribution and efforts of primary care and community care nurses throughout the UK.

As part of our campaign, Nursing in Practice is looking to call on parliament to set up a debate to celebrate the vital work that you do.


GET INVOLVED: SIGN OUR E-PETITION

Close

Calling all primary care nurses! 'Like' our Nursing in Practice Facebook page to enter our free draw to win a £25 M&S voucher




http://www.facebook.com/NursinginPracticeMagazine